Calithera Biosciences (CALA) Financials

$0.00

$-0.03 (-99.04%)

As on 04-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	9.75	--	--	22.25	25.96
Cost of Revenue	1.39	1.43	1.87	76.29	66.20	43.11
Gross Profit	-1.39	8.32	-1.87	-76.29	22.25	25.96
Operating Expenses	40.69	122.59	91.39	92.90	79.54	55.64
Operating Profit (EBIT)	-42.07	-114.28	-91.39	-92.90	-57.28	-29.69
Other Income	--	--	1.25	3.04	--	--
Profit before Tax	-39.65	-115.09	-90.14	-89.86	-54.63	-27.83
Provision for Tax	-20.78	50.25	-1.61	-3.51	-3.16	-0.37
Profit after Tax (Net Income)	-18.87	-115.09	-88.52	-86.35	-51.47	-27.83
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-115.09	-90.14	-89.86	-54.63	-27.83

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	20.39	8.38	102.37	142.43	126.71	150.31
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.89	42.37	4.82	6.72	1.13	3.12
Current Liabilities	7.39	14.01	18.40	19.62	14.88	39.03
Total Liabilities	28.68	64.76	125.59	168.77	142.73	192.46

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	2.05	3.30	6.88	8.97	2.47	24.79
Current Assets	26.62	61.45	118.70	159.80	140.25	167.67
Total Assets	28.68	64.76	125.59	-259.76	142.73	192.46
Total Debt*	1.67	43.74	6.72	8.20	--	--
Net Current Assets	19.23	47.45	100.30	140.17	125.37	128.64

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-43.61	-66.30	-84.31	-78.75	-64.84	13.75
Cash Flow from Investing Activities	-0.13	7.85	88.96	-10.78	52.80	-98.83
Cash from Financing Activities	9.66	10.67	42.06	98.91	14.63	122.95
Net Cash Inflow / Outflow	--	--	46.71	9.38	2.58	37.87

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-3.88	-30.68	-25.08	-31.37	-26.85	-15.65
Cash EPS ($)	-3.82	-30.60	-24.98	-31.19	-26.59	-15.44
Adjusted Book Value ($)	4.19	2.23	29.01	51.74	66.11	84.54
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-8.96	-17.67	-23.89	-28.61	-33.83	7.73
Free Cash Flow per Share ($)	-8.99	-17.71	-23.91	-28.61	-33.94	7.04

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-50.86	-142.78	-68.17	-62.27	-37.16	-27.80
ROE (%)	-131.13	-207.83	-72.32	-64.16	-37.16	-27.80
ROA (%)	-40.38	-120.93	-60.15	-55.44	-30.71	-22.51
EBIT Margin (%)	--	-1,180.39	--	--	-257.40	-114.37
Net Margin (%)	--	-1,180.39	-7,081.84	-2,845.01	-231.29	-107.21
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	-1.00	--	--	-1.00	-0.14	--
EBIT Growth (%)	65.55	-25.93	1.62	-62.17	-92.96	22.56
Net Profit Growth (%)	83.61	-30.01	-2.52	-67.75	-84.98	26.78
EPS Growth (%)	0.87	-0.22	0.20	-0.17	-0.72	0.57
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-0.84	-0.02	-0.20	-0.18	-0.15	-0.53
Price / Book Value	0.78	0.30	0.17	0.11	0.06	0.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.21	0.12	1.00	1.44	2.26	5.08
Close Price ($)	3.26	13.30	98.20	114.20	80.20	167.00
High Price ($)	14.87	75.20	163.60	138.00	187.00	401.00
Low Price ($)	1.30	12.24	59.80	49.00	71.00	64.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.08	5.22	0.07	0.06	--	--
Short term debt to equity ratio	0.08	0.16	0.02	0.01	--	--
Current Ratio	3.60	4.39	6.45	8.14	9.42	4.30
Quick Ratio	--	--	6.53	8.17	9.56	4.87
Interest Coverage	-1.91	-333.59	--	--	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	8.97	4.40
Asset Turnover	--	0.10	--	--	0.13	0.21
Receivable days	--	28.86	--	--	25.76	16.07
Inventory Days	--	-392.50	-197.57	-5.93	-67.20	-94.72
Payable days	577.81	718.78	395.13	7.90	6.40	6.23
Cash Conversion Cycle	--	-1,082.42	--	--	-47.84	-84.88